TWO HOMOLOGOUS PROTEINS, rBAT and 4F2hc, were identified as members of a protein family related to plasma membrane amino acid transport because they induce high-affinity, broad-specificity amino acid exchanger systems b o,/ -like (1-3) and y / L-like (4-5), respectively, in oocytes. The role of rBAT in the highaffinity renal reabsorption and intestinal absorption of cystine and basic amino acids is well established: 1) rBAT is expressed in the apical plasma membrane of epithelial cells of the proximal straight tubule of the nephron and the small intestine (6, 7) , 2) the expression of rBAT is necessary for the b o,/ -like activity present in the apical plasma membrane of the renal cell line OK (8) , and 3) mutations in the rBAT gene cause cystinuria type I (9-13), an inherited aminoaciduria of cystine and basic amino acids (14) . In contrast, the amino acid transport activity associated with 4F2hc expression is controversial. Human and rat 4F2hc induce y acids) amino acid transport activity in oocytes, which is hybrid-depleted by antisense sequences of rat 4F2hc cDNA (17, 18) ; transient transfection of rat 4F2hc in CHO cells results in a moderate increase in L-isoleucine transport with characteristics of system L (19) .
The mechanism by which rBAT and 4F2hc induce amino acid transport is not clear. Neither is very hydrophobic, and they both have a structural prognosis as type II membrane glycoproteins with a single transmembrane domain (2, 3, 20, 21 ). Tate's group (22) offered experimental evidence that rBAT has four transmembrane domains with cytoplasmic amino and carboxy termini. Nevertheless, this is in contrast to other identified amino acid transporters and transporters in general, which contain 10 to 14 transmembrane domains. This fosters the hypothesis that rBAT and 4F2hc are modulators or subunits of the transporters. The cell surface antigen 4F2 is a heterodimer (Ç125 kDa) composed of a heavy chain of 85 kDa (4F2hc, i.e., the homologous protein to rBAT) and an unidentified light chain of 40 kDa, which are believed to be linked by disulfide bridges (23, 24) . Similarly, Tate's group (25) reported the presence of rBAT complexes in brush border preparations from kidney and intestine or in oocytes. In our hands, renal rBAT is immunodetected in nonreducing conditions as complexes of Ç240 kDa and Ç125 kDa (26) . It therefore seems that rBAT has a heterodimeric structure (125 kDa) consisting of a 'heavy chain' (Ç90 kDa), probably linked by disulfide bridges to a putative 'light chain' of 40-50 kDa.
The aim of this study was to investigate whether 4F2hc by itself constitutes the system y / L-like transporter. Here we show dissociation between the expression of 4F2hc at the oocyte surface and induction of system y / L-like activity, which indicates that this expression is limited by an endogenous factor. In addition, we show that y / L transporters induced in oocytes by cysteine-free human 4F2hc are sensitive to sulfhydryl-specific reagents that modify cysteine residue(s) exposed to the aqueous solvent. Sensitivity to inactivation is increased in reducing conditions and in 4F2hc mutants in which the cysteine residue at position 109 has been mutated to serine. These results indicate that 4F2hc is intimately associated with a membrane oocyte protein for the expression of system y / L amino acid transport activity. The increased Hg 2/ reactivity of C109S-containing mutants supports the possibility that C109 may be linked by a disulfide bond to the Hg 2/ -targeted cysteine residue of the associated protein.
MATERIALS AND METHODS

Oocytes, injections, and uptake measurements
Oocyte origin, management, and injections were as described elsewhere (10) . Defolliculated stage IV Xenopus laevis oocytes were injected with different amounts of human 4F2hc or mouse CAT1 or CAT2 cRNA, as indicated. For saturating induction of amino acid transport, oocytes were injected with 1 to 20 ng of human 4F2hc cRNA. Except where indicated, noninjected oocytes were used as controls; amino acid uptake rates obtained with oocytes injected with water (50 nl) were similar to those of noninjected oocytes (data not shown). Synthesis of human 4F2hc [cDNA cloned in EcoRI-HindIII pSPORT-1, from the original cDNA cloned in pSP65 by Teixeria et al. (21) ], and mouse CAT1 (27) and CAT2 (28) cRNAs is described elsewhere (15) .
Influx rates of L-[ ]leucine were measured in 100 mM NaCl (sodium medium) or 100 mM choline Cl (choline medium) media on the days indicated after injection and in linear conditions, as described elsewhere (15) . When present, the induced uptake was calculated by subtracting uptake values in noninjected oocytes from those of the corresponding cRNA-injected oocytes.
The thiol-specific reagents in this study [pCMB (p-chloromercuribenzoic acid), pCMBS (p-chloromercuriphenylsulfonic acid; monosodium salt), and HgCl 2 ] 2 to treat oocytes were from Sigma (St. Louis, Mo.) and were used as described in the corresponding figure legends.
Uptake measurements in human erythrocytes
L-[
14 C]Lysine influx was determined as described previously (29) . Briefly, cells were suspended at 10% hematocrit in a medium containing NaCl (140 mM), KCl (4 mM), and sodium phosphate (5 mM) at pH 6.8, and the uptake of labeled lysine was measured as a function of time. All determinations were performed in duplicate and rates (mean{SEM) were determined from linear regression analysis of six time points, up to 4 min. System y / L activity was estimated as the transport component inhibited by 2 mM L-leucine; the residual activity was attributed to system y / , as demonstrated in previous studies (29, 30) . When necessary, cells (5% hematocrit) were treated at 25ЊC with pCMBS and/or b-mercaptoethanol for 10 min. The same buffer was used throughout. The treatment was stopped by centrifugation at 4ЊC, and the cells were washed three times between treatments or prior to uptake measurements. Uptake data are expressed in nmol/l cell water per min.
Site-directed mutagenesis
For construction of the C109S and C330S human 4F2hc mutants, we used the QuickChange Site-Directed Mutagenesis Kit (Stratagene), following the manufacturer's protocol. The mutagenic oligonucleotides were 5-TAGCTCGCGA(G)AACG-CGGCGC-3 (antisense strand; the mutated nucleotide at position 326 is indicated in parentheses) and 5-ACTCCAG-CTG(G)ACCAGCGATT-3 (antisense strand; the mutated nucleotide at position 989 is indicated in parentheses) for the C109S and C330S, respectively. Mutants were identified by sequencing; a cassette between SphI and SacI sites for the C109S mutant and one between BsmI and Eco47III sites for the C330S mutant were completely sequenced. The first cassette was then substituted into human 4F2hc cDNA inserted in pSP65 (21) , where SphI and SacI sites were removed by digestion with these enzymes and being polished with Klenow. The second cassette was substituted into human 4F2hc inserted in pSPORT (15) with a similar strategy, using BsmI and EcoIII sites. Finally, the 2 Abbreviations: pCMB, p-chloromercuribenzoic acid; p-CMBS, p-chloromercuriphenylsulfonic acid; PBS, phosphatebuffered saline; PBSm, modified PBS; FBS, fetal bovine serum. two inserted cassettes were checked by complete sequencing. For the construction of the Cys-less mutant, a fragment of the pSP65-human 4F2hc-C109S, comprised between the restriction sites EcoRI and SacI, was purified and ligated into p-SPORT-human 4F2hc-C330S, which was cut with the same enzymes. The cassettes were checked again by sequencing after ligations.
Confocal immunofluorescence microscopy
Groups of five oocytes were prepared for immunofluorescence 4 days after injection of a maximal (0.1 ng per oocyte) or supramaximal (20 ng per oocyte) dose of human 4F2 cRNA or were not injected. The oocytes were placed on a 1 cm 2 piece of Whatman 3M paper, embedded in O.C.T. compound (Agar Scientific Ltd., Essex, England), frozen on dry ice, and stored at 080ЊC. Sections (15 mm) were mounted on glass slides coated with 0.5% gelatin and dried at 37ЊC for 10 min. The sections were fixed in 3% paraformaldehyde phosphate-buffered saline (PBS) for 10 min, incubated in 100 mM glycine-PBS for 10 min, permeabilized in 1% Triton-X-100 in PBS for 10 min, washed three times in PBS, blocked in 10% fetal bovine serum (FBS) in PBS for 30 min, and exposed to primary antibody (mouse monoclonal antibody CD98 from Immunotech, Marseille, France), diluted 1/50 in 10% FBS-PBS, at room temperature for 1 h. Slides were washed three times in PBS, incubated with 7.5 mg/ml Texas red-conjugated goat anti-mouse (Molecular Probes, Leiden, The Netherlands) at room temperature for 1 h, washed three times in PBS, and mounted in immunofluore (ICN; Madrid, Spain). With a similar protocol, the oocyte b1-integrin was detected using 8C8 antibody, kindly provided by Dr. A. H. J. Muller (Max Planck Institute für Entwicklingsbiologie, Tü bingen, Germany). Confocal microscopy was performed at the Serveis Científico Tèc-nics of the Universitat de Barcelona.
Binding assays of 4F2hc on the oocyte surface
Four days after injection, binding of the primary antibody (mouse monoclonal antibody anti-CD98 from Immunotech, Marseille, France) to oocytes expressing human 4F2hc and to noninjected oocytes was assayed. Eight oocytes in each experimental group were transferred to a 1.5 ml Eppendorf tube containing a modified PBS buffer (PBSm) [137 mM NaCl, 9 mM Na 2 HPO 4 , 1.4 mM NaH 2 PO 4 (pH 7.4) and 2% (w/v) ovalbumin]. The oocytes were then washed three times in buffer, incubated for 3 h in 0.5 ml of 1:25 primary antibody diluted in PBSm at 4ЊC, washed three times in PBSm, incubated in 0.4 ml of 1:200 dilution of biotinylated goat anti-mouse antibody (Sigma) for 1 h at 4ЊC, washed three times, and finally incubated in 0.3 ml with 0.3 mCi [ 125 I] streptavidin (Amersham, Arlington Heights, Ill.) for 1 h at room temperature and washed. The radioactivity was assessed directly by a gamma counter. The background binding (i.e., radioactivity associated with noninjected oocytes) was 5600 { 500 cpm in three groups of eight oocytes.
RESULTS
Expression of the 4F2hc-associated amino acid transport in Xenopus oocytes is saturated at very low amounts of injected cRNA Figure 1 shows the dose-response curve of expression of sodium-independent L-[ 3 H]arginine uptake by human 4F2hc cRNA compared with that induced by the mouse cationic amino acid transporter CAT1 (mCAT1). At 3 days after injection, maximal transport activity was reached at 0.05-0.1 ng cRNA of human 4F2hc per oocyte (Fig. 1) ; 6 days after injection, saturation of transport expression was reached at an even lower amount of cRNA (0.01-0.05 ng cRNA per oocyte; nÅtwo independent experiments with different cRNA preparations and oocyte batches; data not shown). The 4F2hc-induced system y / L-like transport activity in oocytes is characterized by sodium-independent cationic amino acid transport and sodium-dependent transport of neutral amino acids (4, 5) . Similarly, the 4F2hc-induced sodiumdependent L-leucine uptake in oocytes showed the same saturation curve as the induced sodium-independent Larginine uptake (data not shown). Finally, the amino acid transport induced both at high (25 ng per oocyte) and low (0.1 ng per oocyte) amounts of 4F2hc cRNA injected showed the characteristic pattern of inhibition of system y / L-like activity (i.e., sodium-independent Larginine transport inhibited by L-leucine in the presence of sodium, and sodium-dependent L-leucine transport inhibited by L-arginine) (data not shown; nÅ7 independent experiments). In summary, human 4F2hc induced y / L-like transport activity that saturates at very low amounts of injected cRNA. This is at odds with the doseresponse curve of the uptake induced by the expression of proteins with the 'typical' structure of a transporter protein, i.e., proteins with 12 to 14 transmembrane domains. Thus, the transport induced by mCAT1, mCAT2, and GLUT1 saturates at 1 ng (see Fig. 1 
L-like activity in oocytes
We next examined whether the 4F2hc protein expressed at the oocyte surface correlates with the induced y / L-like transport activity. We first performed experiments of immunocytochemistry in oocytes by using an antibody directed to CD98 (human 4F2hc) with noninjected oocytes and with oocytes injected with 0.1 ng (maximal dose) or 20 ng (supramaximal dose) of human 4F2hc cRNA (Fig. 2A) . The intensity of fluorescence at the oocyte periphery was higher for oocytes injected with 20 ng than with 0.1 ng ( Fig.  2A) , but the induced sodium-independent L-arginine uptake in both sets of oocytes was similar (data not shown). By quantifying the density of fluorescence (i.e., intensity of fluorescence/measured area), we found a difference of 38-fold between oocytes injected with 0.1 or 20 ng of human 4F2hc (658 { 120 arbitrary units for 20 ng; nÅthree independent experiments, 24 { 7 arbitrary units for 0.1 ng; nÅfour independent experiments, and 7 { 1 arbitrary units for noninjected oocytes; nÅ3 independent experiments). The 4F2hc-associated fluorescence at the oocyte surface was similar to that of the b 1 -integrin protein, which localized to the oocyte plasma membrane (data not shown). Part of the endoplasmic reticulum in the Xenopus oocyte is very close to the plasma membrane, so it is difficult to conclude that the 4F2hc-associated fluorescence signal at the oocyte periphery corresponds to 4F2hc expressed at the oocyte plasma membrane. For this reason, we performed surface binding assays with anti-4F2hc antibody in intact oocytes, a method similar to that described by Wang and Goldstein (32) . Injection of a supramaximal dose of 4F2hc cRNA (20 ng per oocyte) resulted in higher expression of the 4F2hc protein at the oocyte surface than did injection of a maximal dose of 4F2hc cRNA (0.1 ng per oocyte) (Fig. 2B ). In contrast, the sodium-independent 4F2hc-induced uptake of L- Three days after injection with saturating amounts of human 4F2hc cRNA, groups of seven or eight 4F2hc-injected and noninjected oocytes were incubated with 1 mM of the indicated organic mercury agents (pCMBS or pCMB) for 5 min. These agents were dissolved in 100 mM choline Cl medium (see ref 15 and Materials and Methods) containing 0.01% DMSO and 10 mM EDTA (to chelate free Hg 2/ ) for pCMB and 10 mM EDTA for pCMBS. Control oocytes were incubated in the same conditions and medium, but without the organic mercury agents and other chemicals. Previous experiments showed that 0.01% DMSO and 10 mM EDTA did not modify 4F2hc-induced amino acid uptake (data not shown). Then, oocytes treated with organic mercury agents and control oocytes were rinsed three times in 3 ml of 100 mM choline Cl medium and incubated for 5 min with 100 mM choline Cl medium with or without 5 mM b-mercaptoethanol, as indicated. Prior to 50 mM L-[ y / L-like activity in oocytes. This supports the hypothesis that an oocyte factor limits the 4F2hc-induced y / L-like transport activity.
Human 4F2hc-induced amino acid uptake was inactivated by covalent modification of external cysteine residue(s)
Organic mercury compounds (pCMB and pCMBS) and Hg 2/ blocked human 4F2hc-induced amino acid transport activity in oocytes. As shown in Fig. 3 , both the water-soluble, membrane-impermeant pCMBS and the membrane-permeant, pCMB thiol-specific reagents inactivated this amino acid transport activity to the same extent. Similarly, Hg 2/ blocked this induced transport activity (see Figs. 5, 8, and 9) .
activity by these thiol-specific reagents exhibited characteristics expected for covalent modification of cysteine residues; it was not reversed upon washout, but was almost completely reversed by bmercaptoethanol (see Figs. 3 and 7) . These results indicate that covalent modification of external cysteine residues inactivates 4F2hc-induced amino acid transport activity (i.e., system y / L) in oocytes. System y / L was first described in human erythrocytes (29) . So we next examined whether covalent modification of external cysteine residues also inactivated erythrocyte system y / L. Treatment with 50 mM pCMBS for 10 min halved the uptake of 1 mM L-[
14 C] lysine (Fig. 4) . System y / L and y / are responsible for L-lysine uptake in human erythrocytes; flux of 1 mM L-lysine through system y / L is fully inhibited by 2 mM L-leucine in the presence of 140 mM sodium, whereas that through system y / is unaffected (29, 30 ). Here we show that Ç50% of the total flux of 1 mM Llysine occurs via system y / L in human erythrocytes (Fig. 4) , which is consistent with previous reports (29, 30) . System y / L was fully inactivated by 50 mM pCMBS for 10 min whereas system y / was unaffected (Fig. 4) . This inactivation of L-lysine uptake was reversed by b-mercaptoethanol (Fig. 4) . Therefore, the results in this section indicate that covalent modification of external cysteine residues inactivated system y Protein labeling and immunoprecipitation studies suggested that 4F2hc is linked by disulfide bridges to a light subunit (23, 24) . Pretreatment with the reducing agent b-mercaptoethanol (Fig. 5) did not alter the amino acid transport induced by 4F2hc in oocytes. In contrast, pretreatment with b-mercaptoethanol increased sensitivity to inactivation by Hg 2/ (Fig. 5) . This suggests that reduction of disulfide bridges increases the exposure of cysteine residue(s) of 4F2hc/system y / L to Hg 2/ either because the Hg 2/ -targeted residues are involved in these bonds or due to indirect steric effects. In addition, these results indicate that the presence of disulfide bridges might not be necessary for the amino acid transport function of 4F2hc. with a topology model as a type II membrane glycoprotein (20, 21) . This may explain the inactivation of amino acid transport by pCMBS and the other thiolspecific reagents. To look for the cysteine residue that is the target of this inactivation, we mutated these two residues to serine either singly (C109S, CS1; C330S, CS2) or in combination (C109S-C330S, Cys-less). CS2/4F2hc induced system y / L-like amino acid transport activity (i.e., sodium-independent transport of L-arginine, sodium-dependent transport of L-leucine, and very little sodium-independent transport of L-leucine) in oocytes to an extent similar to wild type 4F2hc (Fig. 6A) . In contrast, C109S-containing mutants (i.e., CS1 and Cys-less) retained only partial (30 to 50% of wild type) y / L-like transport activity when expressed in oocytes (Fig. 6A and Table  1 ). CS1 and Cys-less showed reduced V max but unaltered K 0.5 of the induced transport in oocytes (Table 1).
C109S-containing mutants retain partial y
It is known that system 4F2hc/y / L has an exchange mechanism of transport (15) . To test whether CS1 mutant affected this transport mechanism, the efflux of L-[ 3 H]arginine was measured in oocytes expressing wild type or CS1 4F2hc. To load both sets of oocytes with a similar amount of labeled L-arginine, oocytes injected with wild type and CS1 4F2hc mutant were loaded with 50 mM L-[ 3 H]arginine for 30 and 90 min, respectively (see inset in Fig. 6B ). Then, efflux of L-[ 3 H]arginine toward media containing no amino acid substrates or 1 mM L-arginine was measured. As previously described (15) , efflux from wild type 4F2hc-injected oocytes was totally dependent on the presence of substrate (i.e., L-arginine) in the medium (Fig. 6B ). This was also true for CS1 4F2hc mu- tant injected-oocytes, but the efflux rate was Ç50% of that of wild type 4F2hc-injected oocytes. This demonstrated that the CS1 mutant does not affect the exchange mechanism of system 4F2hc/y / L, but reduces the induced system y / L activity. Therefore, all the results in this section are compatible with reduced intrinsic transport activity of system y / L induced by C109S-containing 4F2hc mutants and/or reduced active transport protein in the plasma membrane.
Cys-less 4F2hc-induced y / L transport activity is inactivated by covalent modification of external cysteine residue(s)
The Cys-less 4F2hc mutant showed induced y / L-like transport activity, which was completely inactivated by 0.1 mM Hg 2/ and the water-soluble, membraneimpermeant thiol-specific reagent pCMBS (Fig. 7) . Again, this inactivation had the characteristics expected for covalent modification of cysteine residues: it was not reversed upon washout and was completely reversed by b-mercaptoethanol (Fig. 7) . This suggests that complete inactivation of the y / L transporter function is caused by the modification of a non-4F2hc external cysteine-bearing protein.
Increased sensitivity to Hg 2/ inactivation of C109S-containing mutants
The above results suggested an increased sensitivity to inactivation by thiol-specific reagents of the y (Fig. 7) . Indeed, sensitivity to Hg 2/ inactivation increased in C109S-containing mutants (i.e., CS1 and Cys-less) (Fig. 8) . Hg 2/ at 10 mM completely inactivated the arginine uptake induced by CS1 and Cys-less mutants in 20 min, whereas under these conditions and in this experiment, wild type and CS2 4F2hc were inactivated only partially (approx 40%). Inactivation of wild type 4F2hc-induced system y / L-like activity varies with different batches of oocytes, and in this experiment it was larger than in the experiments shown in Fig. 5 . In an additional experiment, the increased sensitivity to Hg 2/ inactivation of Cys-less 4F2hc-induced system y / L-like activity was confirmed: 10 mM Hg 2/ in 30 s completely inactivated Cys-less 4F2hc-induced arginine uptake but did not affect wild type 4F2hc-induced arginine uptake (data not shown). This, together with the increased sensitivity to thiolspecific reagents after b-mercaptoethanol treatment (Fig. 5) , could be explained in two ways: 1) residue C109 forms a disulfide bond with a cysteine residue of a 4F2hc-associated protein, which is the target of the thiol-specific reagent inactivation, or 2) mutation of residue C109 to serine increases the accessibility of Hg 2/ to an otherwise hidden external cysteine residue(s) of a native 4F2hc-associated protein. In any case, these data demonstrate the functional interaction of expressed 4F2hc and an oocyte plasma membrane protein to form active y 
a Three days after injection of saturating amounts of wild type (Wt), CS1 mutant, or cysteine-free (Cys-less) human 4F2hc cRNA, the uptake of L-[ 
DISCUSSION
We have shown that induction of system y / L amino acid transport activity by 4F2hc in oocytes is limited by endogenous factors: saturation of induction occurs with very low expression of 4F2hc at the oocyte surface, and further increased expression of the protein at the cell surface does not result in higher induction of the transport activity. In addition, we demonstrate that Hg 2/ and two organic mercury compounds inactivate 4F2hc-induced y / L activity. The reagents act in the extracellular medium since the membrane-impermeant thiol-specific reagent pCMBS inactivates transport to the same extent as the membrane-permeant pCMB. Similarly, human erythrocyte system y / L is also inactivated by pCMBS. These reagents inactivate cysteine-free 4F2hc/system y / L. In all cases, inactivation is reversed by b-mercaptoethanol. This shows that external cysteine residue modification of a plasma membrane protein of the oocyte leads to inactivation of 4F2hc-induced y / L activity. Finally, reduction with b-mercaptoethanol of oocytes expressing 4F2hc increased sensitivity to Hg 2/ inactivation of system y / L. Similarly, C109S-containing mutants (CS1 and cysteine-free 4F2hc; Cysless) showed increased sensitivity to Hg 2/ inactivation. These results support that the y / L amino acid transport system is formed through the intimate association of 4F2hc and an oocyte plasma membrane protein. These results also suggest that cysteine residue 109 of human 4F2hc may be linked by a disulfide bond to the Hg 2/ -targeted cysteine residue of the 4F2hc-associated protein. The fact that reduction by b-mercaptoethanol does not result in decreased system 4F2hc/y / L activity suggests that the 4F2hc-associated protein does not diffuse away from 4F2hc due to protein interactions other than disulfide bonds or that, after diffusion from 4F2hc, the associated protein remains fully active for transport. The experimental approach used in this study cannot discriminate between these two possibilities, nor does it show the number of associated proteins that form the functional heteromultimeric structure of 4F2hc/system y / L or their identity. In contrast, it allows us to propose that the oocyte factor limiting y / L activity and the 4F2hc-associated protein bearing external cysteine residue(s), which is susceptible to modificationinactivation, might be the light chain of 4F2hc revealed by previous labeling and immunoprecipitation studies (23, 24) .
The mechanisms by which 4F2hc and rBAT induce amino acid transport systems y (22, 26) , and the 125 kDa rBAT complex is not detected (26) .
2) The loss of function of Met467Thr rBAT, the most frequent cystinuria type I mutant known, is due to a defect in trafficking to the plasma membrane that affects the V max of the induced transport in oocytes (10) . Long oocyte expression periods and injection of oversaturating amounts of mutant rBAT cRNA resulted in total recovery of the induced amino acid transport. Under these conditions, the amount of Met467 Thr rBAT on the oocyte surface is only õ10% of the corresponding wild type protein (10).
3) A carboxy terminus-deleted (D511-685) human rBAT induces an amino acid transport activity in oocytes with some of the characteristics of 4F2hc/system y ]leucine uptake was measured in the presence of 100 mM sodium (sodium Cl medium). Uptake values in the noninjected oocytes were (pmol/10 min per oocyte; mean{SEM): 1.7 { 0.1, control group; 1.7 { 0.05, pCMBS-treated group; 1.6 { 0.05, pCMBS-and b-mercaptoethanol-treated group. 4F2hc-induced uptake (see Materials and Methods) is expressed in pmol/10 min per oocyte (mean{SEM). A, B) All reagents were dissolved in 100 mM choline Cl medium or 100 mM sodium Cl medium, depending on the transport to be measured: sodium-independent L-arginine or sodium-dependent L-leucine uptake, respectively. These media were used as control solutions; oocytes were rinsed after each treatment, as indicated in the legend to Fig. 4 . Taylor's groups (35, 36) reported that rBAT induces several amino acid transport systems in oocytes, including system b o,/ -like and a sodium-dependent histidine transport system with comparable activity, whereas the others are not very conspicuous. Similarly, Bröer's group (18, 37) The results presented here indicate that 4F2hc is intimately associated with a membrane oocyte protein for the expression of system y / L amino acid transport activity. Induction of transport activities in oocytes by the expression of foreign proteins that associate with endogenous subunits has been described for Na / /K / ATPase (38) and potassium multimeric channels (39) (40) (41) the first direct evidence for a heteromultimeric structure of MinK channels came from studies of cysteine residue modification of the channel activity induced by cysteine-free MinK in oocytes (42) . The increased sensitivity to Hg 2/ inactivation of the C109S-containing mutants shown here suggests that this residue participates in a disulfide bridge with a cystine residue of an oocyte 4F2hc-associated protein, which is the target of the Hg 2/ inactivation of system y / L. A similar approach has been used to identify an intracatenary disulfide bridge in the second external loop of the serotonine transporter (43) . Human 4F2hc-C109 residue is conserved in all known 4F2hc sequences (18, 20, 21, 44) and is the only cysteine residue of 4F2hc proteins conserved in all known rBAT sequences (cysteine residue 114 in human rBAT) (1-3, 45, 46) . Additional work is needed to demonstrate functional association of rBAT with an endogenous plasma membrane protein through residue C114 in human rBAT. It has been shown that rBAT/system b o,/ is inactivated mainly through modification of intracellular cysteine residues (47) . This suggests that the experimental approach used in the present study may not be suitable for rBAT/system b o,/ . We are far from establishing the physiological role of 4F2hc in amino acid transport. Several labs reported induction of amino acid transport in oocytes injected with 4F2hc cRNA. Human (4, 5, 15, 16 ; this study) and rat (R. Estévez, A. Zorzano, and M. Palacín, unpublished results) 4F2hc induced y / L-like transport activity. In contrast, Bröer's group (17, 18) found induction of a system L-like transport activity by injecting rat glioma culture cell mRNA in oocytes, which is hybrid-depleted by rat 4F2hc antisense sequences. Expression cloning from this transport signal resulted in the isolation of rat 4F2hc cDNA (18) . Injection of this cRNA into oocytes resulted in the induction of amino acid transport compatible with the simultaneous expression of systems y -like after injection of oocytes with human or rat 4F2hc (4, 5, 15) , and with mRNA from human choriocarcinoma cells (16) , rat glioma culture cells (18) , and rat lung (R. Estévez, A. Zorzano, and M. Palacín, unpublished results). Purification studies of the 4F2hc complex and screening of a rat lung cDNA library after coexpression of system y / L activity by injecting saturating amounts of 4F2hc cRNA and rat lung mRNA (R. Estévez, A. Zorzano, and M. Palacín, unpublished results) are currently in progress in an attempt to identify 4F2 light chain subunit(s).
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